Hui‐Ping Hsu
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism 9
- Oncology top 5%
- Cancer Cells and Metastasis 9
- Pancreatic and Hepatic Oncology Research 9
- Cancer-related Molecular Pathways 7
- Biotechnology top 5%
- Cancer Research and Treatments 8
- Molecular Biology top 10%
- Epigenetics and DNA Methylation 5
-
- Immune cells in cancer 6
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 5
Hui‐Ping Hsu
66 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 111
- Cancer Research 384
- Oncology 489
- Radiological and Ultrasound Technology 73
- Biotechnology 96
- Molecular Biology 695
Countries citing papers authored by Hui‐Ping Hsu
This map shows the geographic impact of Hui‐Ping Hsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui‐Ping Hsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui‐Ping Hsu more than expected).
Fields of papers citing papers by Hui‐Ping Hsu
This network shows the impact of papers produced by Hui‐Ping Hsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui‐Ping Hsu. The network helps show where Hui‐Ping Hsu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hui‐Ping Hsu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 3 | |
| 3 | 2023 | 36 | |
| 4 | 2021 | 5 | |
| 5 | 2021 | 3 | |
| 6 | 2020 | 30 | |
| 7 | 2020 | 23 | |
| 8 | 2019 | 22 | |
| 9 | 2019 | 7 | |
| 10 | 2018 | 35 | |
| 11 | 2015 | 1 | |
| 12 | 2015 | 46 | |
| 13 | 2013 | 28 | |
| 14 | 2013 | 18 | |
| 15 | 2010 | 15 | |
| 16 | 2010 | 23 | |
| 17 | 2007 | 61 | |
| 18 | 2006 | 79 | |
| 19 | 2006 | 7 | |
| 20 | 1998 | 106 |
About Hui‐Ping Hsu
Hui‐Ping Hsu is a scholar working on Cancer Research, Oncology and Biotechnology, having authored 67 papers that have together received 1.5k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (9 papers), Pancreatic and Hepatic Oncology Research (9 papers), Cancer, Hypoxia, and Metabolism (9 papers), Cancer Research and Treatments (8 papers), Cancer-related Molecular Pathways (7 papers), Immune cells in cancer (6 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers) and Epigenetics and DNA Methylation (5 papers). The work is most often cited by research in Cancer Research (384 citations), Oncology (489 citations) and Radiological and Ultrasound Technology (73 citations). Hui‐Ping Hsu has collaborated with scholars based in Taiwan, United States and Vietnam. Frequent co-authors include Chih‐Yang Wang, Yan‐Shen Shan, Ming-Derg Lai, Meng‐Chi Yen, Yi‐Ling Chen, Ming‐Derg Lai, Nam Nhut Phan, Pin-Wen Lin, Wei-Ching Chen and Tzu‐Yang Weng. Their work appears in journals such as Oncology Reports, Scientific Reports, International Journal of Medical Sciences, Oncotarget and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.